Biochanin a reduces drug-induced p75NTR expression and enhances cell survival: A new in vitro assay for screening inhibitors of p75NTR expression

Rejuvenation Research

Volumn 13, Issue 5, 2010, Pages 527-537

  El Touny, Lara H ^a   Henderson, Fraser ^b,c   Djakiew, Daniel ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Doctors Community Hospital   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BIOCHANIN A; DEXAMETHASONE; ESTRADIOL; GENISTEIN; IBUPROFEN; METHYLPREDNISOLONE SODIUM SUCCINATE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROTROPHIN RECEPTOR P75; PHYTOESTROGEN;

ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SCREENING; ENZYME INACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; SPINAL CORD INJURY;

BIOLOGICAL ASSAY; CELL LINE, TUMOR; CELL SURVIVAL; DEXAMETHASONE; DRUG EVALUATION, PRECLINICAL; ENZYME ACTIVATION; GENISTEIN; HUMANS; IBUPROFEN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECEPTORS, NERVE GROWTH FACTOR; RNA, SMALL INTERFERING; TIME FACTORS;

ANIMALIA; RODENTIA;

EID: 78650002296     PISSN: 15491684     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.2009.1006     Document Type: Article

References (48)

1. Kalb R. The protean actions of neurotrophins and their receptors on the life and death of neurons. Trends Neurosci 2005;28:5-11.
2. Hall ED, Braughler JM. Non-surgical management of spinal cord injuries: A review of studies with the glucocorticoid steroid methylprednisolone. Acta Anaesthesiol Belg 1987;38: 405-409.
3. Bracken MB, Shepard MJ, Holford TR, Leo-Summers L, Aldrich EF, Fazl M, Fehlings M, Herr DL, Hitchon PW, Marshall LF, Nockels RP, Pascale V, Perot PL Jr, Piepmeier J, Sonntag VK, Wagner F, Wilberger JE, Winn HR, Young W. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 1997;277: 1597-1604.
4. Tsutsumi S, Ueta T, Shiba K, Yamamoto S, Takagishi K. Effects of the Second National Acute Spinal Cord Injury Study of high-dose methylprednisolone therapy on acute cervical spinal cord injury-results in spinal injuries center. Spine 2006;31:2992-2996.
5. Brandoli C, Shi B, Pflug B, Andrews P, Wrathall JR, Mocchetti I. Dexamethasone reduces the expression of p75 neurotrophin receptor and apoptosis in contused spinal cord. Brain Res Mol Brain Res 2001;87:61-70.
6. Gorio A, Madaschi L, Di Stefano B, Carelli S, Di Giulio AM, De Biasi S, Coleman T, Cerami A, Brines M. Methylpredni-solone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury. Proc Natl Acad Sci USA 2005;102:16379-16384.
7. Matsumoto T, Tamaki T, Kawakami M, Yoshida M, Ando M, Yamada H. Early complications of high-dose methyl-prednisolone sodium succinate treatment in the follow-up of acute cervical spinal cord injury. Spine 2001;26:426-430.
8. Schumacher M, Guennoun R, Stein DG, De Nicola AF. Progesterone: Therapeutic opportunities for neuroprotection and myelin repair. Pharmacol Ther 2007;116:77-106.
9. Fee DB, Swartz KR, Joy KM, Roberts KN, Scheff NN, Scheff SW. Effects of progesterone on experimental spinal cord injury. Brain Res 2007;1137:146-152.
10. Jones KJ, Brown TJ, Damaser M. Neuroprotective effects of gonadal steroids on regenerating peripheral motoneurons. Brain Res Brain Res Rev 2001;37:372-382.
11. Schopp LH, Clark M, Mazurek MO, Hagglund KJ, Acuff ME, Sherman AK, Childers MK. Testosterone levels among men with spinal cord injury admitted to inpatient rehabilitation. Am J Phys Med Rehabil 2006;85:678-684.
12. Chaovipoch P, Jelks KA, Gerhold LM, West EJ, Chongth-ammakun S, Floyd CL. 17beta-estradiol is protective in spinal cord injury in post- and pre-menopausal rats. J Neu-rotrauma 2006;23:830-852.
13. Cordey M, Gundimeda U, Gopalakrishna R, Pike CJ. Estrogen activates protein kinase C in neurons: Role in neu-roprotection. J Neurochem 2003;84:1340-1348.
14. Smith SS, Woolley CS. Cellular and molecular effects of steroid hormones on CNS excitability. Cleveland Clin J Med 2004;71:S4-S10.
15. Tabassum A, Khwaja F, Djakiew D. The p75(NTR) tumor suppressor induces caspase-mediated apoptosis in bladder tumor cells. Int J Cancer 2003;105:47-52.
16. Khwaja F, Allen J, Lynch J, Andrews P, Djakiew D. Ibu-profen inhibits survival of bladder cancer cells by induced expression of the p75NTR tumor suppressor protein. Cancer Res 2004;64:6207-6213.
17. Quann EJ, Khwaja F, Zavitz KH, Djakiew D. The aryl pro-pionic acid R-flurbiprofen selectively induces p75NTR-dependent decreased survival of prostate tumor cells. Cancer Res 2007;67:3254-3262.
18. Khwaja F, Tabassum A, Allen J, Djakiew D.The p75(NTR) tumor suppressor induces cell cycle arrest facilitating cas-pase mediated apoptosis in prostate tumor cells. Biochem Biophys Res Commun 2006;341:1184-1192.
19. Krygier S, Djakiew D. Molecular characterization of the loss of p75(NTR) expression in human prostate tumor cells. Mol Carcinog 2001;31:46-55.
20. Yan P, Liu N, Kim GM, Xu J, Xu J, Li Q, Hsu CY, Xu XM. Expression of the type 1 and type 2 receptors for tumor necrosis factor after traumatic spinal cord injury in adult rats. Exp Neurol 2003;183:286-297.
21. Lowry KS, Murray SS, Coulson EJ, Epa R, Bartlett PF, Barrett G, Cheema SS. Systemic administration of antisense p75(NTR) oligodeoxynucleotides rescues axotomised spinal motor neurons. J Neurosci Res 2001;64:11-17.
22. Kuiper GG, Carlsson B, Grandien K, Enmark E, Häggblad J, Nilsson S, Gustafsson JA. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138:863-870.
23. Price KR, Fenwick GR. Naturally occurring oestrogens in foods-a review. Food Addit Contam 1985;2:73-106.
24. Wang SW, Chen Y, Joseph T, Hu M. Variable isoflavone content of red clover products affects intestinal disposition of biochanin A, formononetin, genistein, and daidzein. J Altern Complement Med 2008;14:287-297.
25. Munro IC, Harwood M, Hlywka JJ, Stephen AM, Doull J, Flamm WG, Adlercreutz H. Soy isoflavones: A safety review. Nutr Rev 2003;61:1-33.
26. Allen J, Khwaja F, Byers S, Djakiew D. The p75NTR mediates a bifurcated signal transduction cascade through the NF kappa B and JNK pathways to inhibit cell survival. Exp Cell Res 2005;304:69-80.
27. Quann EJ, Khwaja F, Djakiew D.The p38 MAPK pathway mediates aryl propionic acid induced messenger RNA stability of p75 NTR in prostate cancer cells. Cancer Res 2007;67:11402-11410.
28. Crown ED, Gwak YS, Ye Z, Johnson KM, Hulsebosch CE. Activation of p38 MAP kinase is involved in central neuropathic pain following spinal cord injury. Exp Neurol 2008; 213:257-267.
29. Kwon BK, Tetzlaff W, Grauer JN, Beiner J, Vaccaro AR. Pathophysiology and pharmacologic treatment of acute spinal cord injury. Spine J 2004;4:451-464.
30. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991;75:15-26.
31. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 2001;53:135-159.
32. Wrathall JR, Teng YD, Choiniere D. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors. Exp Neurol 1996;137:119-126.
33. Dusart I, Schwab ME. Secondary cell death and the inflammatory reaction after dorsal hemisection of the rat spinal cord. Eur J Neurosci 1994;6:712-724.
34. Beattie MS, Farooqui AA, Bresnahan JC. Review of current evidence for apoptosis after spinal cord injury. J Neuro-trauma 2000;17:915-925.
35. Dechant G, Barde YA. The neurotrophin receptor p75(NTR): Novel functions and implications for diseases of the nervous system. Nat Neurosci 2002;5:1131-1136.
36. Rende M, Provenzano C, Tonali P. Modulation of low-affinity nerve growth factor receptor in injured adult rat spinal cord motoneurons. J Comp Neurol 1993;338:560-574.
37. Giehl KM, Röhrig S, Bonatz H, Gutjahr M, Leiner B, Bartke I, Yan Q, Reichardt LF, Backus C, Welcher AA, Dethleffsen K, Mestres P, Meyer M. Endogenous brain-derived neuro-trophic factor and neurotrophin-3 antagonistically regulate survival of axotomized corticospinal neurons in vivo. J Neurosci 2001;21:3492-3502.
38. Dobrowsky RT, Werner MH, Castellino AM, Chao MV, Hannun YA. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science 1994;265: 1596-1599.
39. Carter BD, Kaltschmidt C, Kaltschmidt B, Offenhäuser N, Böhm-Matthaei R, Baeuerle PA, Barde YA. Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science 1996;272:542-545.
40. Yune TY, Lee JY, Jung GY, Kim SJ, Jiang MH, Kim YC, Oh YJ, Markelonis GJ, Oh TH. Minocycline alleviates death of oligodendrocytes by inhibiting pro-nerve growth factor production in microglia after spinal cord injury. J Neurosci 2007;27:7751-7761.
41. Shamji MF, Maziak DE, Shamji FM, Ginsberg RJ, Pon R. Circulation of the spinal cord: an important consideration for thoracic surgeons. Ann Thorac Surg 2003;76: 315-321.
42. Moon YJ, Shin BS, An G, Morris ME. Biochanin A inhibits breast cancer tumor growth in a murine xenograft model. Pharm Res 2008;25:2158-2163.
43. Su SJ, Yeh TM, Lei HY, Chow NH. The potential of soybean foods as a chemoprevention approach for human urinary tract cancer. Clin Cancer Res 2000;6:230-236.
44. Wang S, DeGroff VL, Clinton SK. Tomato and soy poly-phenols reduce insulin-like growth factor-I-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase. J Nutr 2003;133:2367-2376.
45. Moon YJ, Sagawa K, Frederick K, Zhang S, Morris ME Pharmacokinetics and bioavailability of the isoflavone bio-chanin A in rats. AAPS J 2006;8:E433-442.
46. Widmann C, Gibson S, Jarpe MB, Johnson GL. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human. Rev 1999;79:143-180.
47. Hains BC, Waxman SG. Activated microglia contributes to the maintenance of chronic pain after spinal cord injury. J Neurosci 2006;26:4308-4317.
48. Ji RR, Suter MR. p38MAPK, microglial signaling, and neuropathic pain. Mol Pain 2007;3:33-41.